ArticleDiabetology & metabolic syndrome2024

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Xiaomei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.